Research Support

Funding Opportunities

Title Description Expires Grant Number
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)

The purpose of this funding opportunity announcement (FOA) is to support clinical studies that will fill gaps in the design of upcoming clinical trials in rare neurological or neuromuscular diseases by validating clinical outcome measures or biomarkers, or by characterizing cohorts of relevant patients. This is the reissue of PAR 18-534 and has replaced PAR 18-534.

Expiration February 17, 2022

PAR-19-220

Information for Researchers

Funding Opportunities for Muscular Dystrophy Research

FY20 Duchenne Muscular Dystrophy Research Program (DMDRP)

Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers

CureDuchenne Ventures 2020 Pitch Contest Submission Deadline: July 13, 2020!

Muscular Dystrophy Research Support from MDCC Member Organizations

2018 Supported Projects
2017 Supported Projects
2016 Supported Projects
2015 Supported Projects
Was this page helpful?
Form Approved OMB# 0925-0648 Exp. Date 05/31/2021